- Product Details
Keywords
- Diabetis
- Insuline
- Glucagon
Quick Details
- ProName: Januvia
- CasNo: 486460-32-6
- Molecular Formula: C16H15F6N5O
- Appearance: Solid
- Application: oral tablets with cas number 486460-32...
- DeliveryTime: Express delivery
- PackAge: Descrete packaging with aluminum foil
- Port: Borispol
- ProductionCapacity: 10 Kilogram/Day
- Purity: 99%
- Storage: Store at room temperature
- Transportation: By air
- LimitNum: 0 Metric Ton
Superiority
Sitagliptin is a new oral hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. This enzyme-inhibiting drug is to be used either alone or in combination with metformin or a thiazolidinedione for control of type 2 diabetes mellitus. The drug works to competitively inhibit a protein/enzyme, dipeptidyl peptidase 4 (DPP-4), that results in an increased amount of active incretins (GLP-1 and GIP), reduced amount of release of glucagon (diminishes its release) and increased release of insulin.